A new study from researchers at Wake Forest University School of Medicine is shedding light on how scientific evidence and the uncertainty surrounding three unproven therapeutics were portrayed by the U.S. news media during the early days of the COVID-19 pandemic.
Cidara axes 30% of staff to focus on flu prevention drug
Cidara reacquired the rights to the therapy from J&J for $85m in April. Image credit: gguy / Shutterstock. Cidara Therapeutics is axing nearly a third
September 13, 2024